Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperilymphatic dexamethasone via round window as salvage therapy for profound sudden sensorineural hearing loss
ChiCTR2600130562Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexamethasone in acute sensorineural hearing loss, sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Overall response rate and Overall safety endpoint. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on ChiCTR2600130562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130562.